Here’s Why Humana (HUM) Stock was Volatile in Q3
PGIM Jennison Health Sciences Fund recently released its third quarter 2024 investor letter. A copy of the letter can be downloaded here. Given concerns regarding the decreasing pace of U.S.
Humana Inc (HUM)
Market is closed
Sector: Hospital & Medical Service Plans
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Eagle Capital Management Boykin Curry | 3,245,790 | $1,028,071,525 | +1% | 3.81% |
| 2. | Pzena Investment Management Richard S. Pzena | 2,506,250 | $793,829,625 | +9% | 2.55% |
| 3. | 1,557,500 | $493,322,550 | +31% | 0.09% | |
| 4. | 1,219,500 | $386,264,430 | +71% | 0.07% | |
| 5. | Two Sigma Advisors John Overdeck And David Siegel | 1,043,580 | $330,543,529 | +3% | 0.77% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $367.09 | 545 | Director | 2,578 | 2024-02-20 | Filing | |
| $403.37 | 375 | Director | 375 | 2021-03-08 | Filing | |
| $289.40 | 1,500 | Officer | 3,162 | 2020-03-13 | Filing | |
| $319.68 | 1,785 | Officer | 2,114 | 2020-02-28 | Filing | |
| $368.63 | 380 | Officer | 380 | 2019-12-24 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $526.75 | 1,500 | Officer | 3,931 | 2023-05-04 | Filing | |
| $526.02 | 2,656 | Officer | 5,431 | 2023-05-04 | Filing | |
| $505.85 | 17,575 | Officer, Director | 70,040 | 2023-02-27 | Filing | |
| $507.97 | 2,048 | Officer | 4,256 | 2023-02-27 | Filing | |
| $510.30 | 2,628 | Officer | 4,968 | 2023-02-27 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,171,109 | $5,114,245,410 | 0.11% | |
| 2. | 10,842,446 | $4,963,779,978 | 0.12% | |
| 3. | 5,833,056 | $2,675,524,406 | 0.13% | |
| 4. | 5,363,011 | $2,455,240,065 | 0.45% | |
| 5. | 4,792,549 | $2,194,076,979 | 0.16% |
News See All
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
Do You Believe in Humana Inc. (HUM)’s Long-Term Strength?
Artisan Partners, an investment management company, released its “Artisan Value Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Several Headwinds Dragged Humana (HUM) in Q3
Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” third-quarter 2024 investor letter. A copy of the letter can be downloaded here.
Humana Inc. (NYSE:HUM) Q3 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to the Humana Third Quarter Earnings Call. At this time, all participants are in a listen-only mode.
10 Oversold Blue Chip Stocks to Buy Now
Market experts believe that, so far, 2024 continues to be a strong year for the broader stock market.
10 Worst Performing Stocks in S&P 500 in 2024
Since 2023, the market has experienced extended winning streaks, reflecting the economy's resilience.
10 Oversold Growth Stocks to Invest In
As investors focus on consumer spending in a bid to assess the broader health of the US economy, current data points demonstrate that the fears of recession are now overdone.
Goldman Sachs' Stocks With Highest Consensus Returns: 42 Stocks With The Highest Consensus ROE
As the fourth quarter of 2024 settles in, the narrative surrounding stocks on Wall Street is starting to shift.
Humana's (HUM) Ratings Plunge Is A Red Flag For Long Term Investors
Humana's stock dived when it announced a sharp decline in memberships for the top-rated Medicare Advantage (MA) plan.
Billionaire Hedge Funds
